Table 2.
Outcome | No. of Events | Event Rate (KM estimate) | Hazard Ratio (95% CI) | P-value |
---|---|---|---|---|
Short-term outcomes | ||||
Death | ||||
EES | 29 | 1.0 | 0.55(0.35,0.87) | 0.01 |
CABG | 51 | 1.7 | Reference | |
MI | ||||
EES | 20 | 0.7 | 1.33(0.68,2.60) | 0.40 |
CABG | 15 | 0.5 | Reference | |
Stroke | ||||
EES | 11 | 0.4 | 0.22(0.12,0.42) | <0.0001 |
CABG | 50 | 0.5 | Reference | |
Repeat Revascularization | ||||
EES | 11 | 0.4 | 0.48(0.23,0.98) | 0.04 |
CABG | 23 | 0.8 | Reference | |
Long-term outcomes | ||||
Death | ||||
EES | 458 | 22.7 | 1.07(0.92,1.24) | 0.40 |
CABG | 469 | 20.5 | Reference | |
MI | ||||
EES | 233 | 10.7 | 1.76(1.4,2.23) | <0.0001 |
CABG | 153 | 7.0 | Reference | |
Stroke | ||||
EES | 90 | 4.5 | 0.56(0.41,0.76) | 0.0002 |
CABG | 143 | 6.4 | Reference | |
Repeat Revascularization | ||||
EES | 582 | 26.1 | 2.42(2.05,2.85) | <0.0001 |
CABG | 284 | 13.1 | Reference |
CABG = coronary artery bypass graft surgery; EES = everolimus eluting stent; MI =myocardial infarction.